Improved blood glucose control in patients switched from metformin and glibenclamide co-administered to a single-tablet metformin-glibenclamide combination treatment (Glucovance®):: a retrospective chart review from four clinics.

被引：0

|

作者：

Howlett, H

Allavoine, T

Bruce, S

Porte, F

机构：

[1] Merck Sante, Lyon, France

[2] Bristol Myers Squibb Inc, Princeton, NJ USA

来源：

DIABETOLOGIA | 2003年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

864

引用

收藏

页码：A299 / A299

页数：1

相关论文

共 2 条

[1] Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes
Garber, A
Marre, M
Blonde, L
Allavoine, T
Howlett, H
Lehert, P
Cornes, M
DIABETES OBESITY & METABOLISM, 2003, 5 (03): : 171 - 179
[2] Effects of a single-tablet metformin-glibenclamidea combination treatment (Glucovance®) on fasting and postprandial plasma insulin in diet-failed Type 2 diabetic patients:: data from two randomised, double-blind trials.
Porte, F
Howlett, H
Bruce, S
Allavoine, T
DIABETOLOGIA, 2003, 46 : A299 - A299